You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HSP90 Inhibitor

Showing 1 - 25 of 9,955
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Durham (HS-196)

Suspended
  • Solid Tumor
  • Durham, North Carolina
    Duke University Medical Center
Dec 19, 2022

Hidradenitis Suppurativa Trial in Aarhus (RGRN-305, Placebo)

Completed
  • Hidradenitis Suppurativa
  • Aarhus, Denmark
    Aarhus University Hospital
Jan 30, 2023

Metastatic or Unresectable Solid Tumor Malignancy Trial in Fort Myers, Oklahoma City, Nashville (Capecitabine, Hsp90 Inhibitor

Completed
Has Results
  • Metastatic or Unresectable Solid Tumor Malignancy
  • Fort Myers, Florida
  • +2 more
Feb 15, 2022

Melanoma Trial in Tampa (XL888, Vemurafenib)

Active, not recruiting
  • Melanoma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 18, 2022

Colorectal Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Colorectal Carcinoma Trial in Atlanta (XL888,

Active, not recruiting
  • Colorectal Adenocarcinoma
  • +14 more
  • Atlanta, Georgia
  • +2 more
Jul 5, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • CDK Inhibitor AT7519
  • +3 more
  • Washington, District of Columbia
  • +5 more
Oct 18, 2022

Recurrent NSCLC, Squamous Cell Lung Cancer, Stage IV NSCLC Trial in Los Angeles (Hsp90 inhibitor AUY922, pemetrexed disodium,

Completed
  • Recurrent Non-small Cell Lung Cancer
  • +2 more
  • Hsp90 inhibitor AUY922
  • +3 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Sep 1, 2020

Stomach Tumors Esophageal Tumors Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein Trial in Worldwide

Completed
  • Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein
  • Boston, Massachusetts
  • +8 more
Dec 6, 2020

Traitment of Acute Lymphoblastique Leukemia With

Recruiting
  • Acute T Lymphoblastic Leukemia (T-ALL)
  • Acute B Lymphoblastic Leukemia (B-ALL)
  • injection of BEP 800
  • Control
  • Dijon, France
    Chu Dijon Bourgogne
Jun 19, 2020

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Worldwide (Ganetespib, Niraparib, Carboplatin)

Unknown status
  • Ovarian Cancer
  • +2 more
  • Innsbruck, Austria
  • +12 more
Jan 26, 2021

Adenocarcinoma of the Lung, NSCLC Trial in Chicago, New York (drug, other, procedure, genetic)

Completed
Has Results
  • Adenocarcinoma of the Lung
  • Non-small Cell Lung Cancer
  • erlotinib hydrochloride
  • +5 more
  • Chicago, Illinois
  • +1 more
Aug 27, 2019

HSP90 in Peripheral Vascular Lesions of Diabetic Atherosclerosis

Completed
  • Peripheral Arterial Disease
  • non-intervention
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Mar 4, 2021

Psoriasis Vulgaris Trial in Aarhus (CUDC-305)

Unknown status
  • Psoriasis Vulgaris
  • Aarhus, Denmark
    Aarhus University Hospital
Jul 9, 2019

Small Cell Lung Cancer Trial in Boston (STA-9090)

Completed
Has Results
  • Small Cell Lung Cancer
  • Boston, Massachusetts
  • +2 more
Apr 12, 2019

Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency Trial in Providence (Palbociclib Oral

Not yet recruiting
  • Advanced Breast Cancer
  • +6 more
  • Providence, Rhode Island
    Lifespan Cancer Institute
Feb 1, 2023

Lymphoma, Advanced Solid Tumor Trial in Philadelphia (Gamitrinib)

Recruiting
  • Lymphoma
  • Advanced Solid Tumor
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Feb 2, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Worldwide (Ganetespib, Paclitaxel)

Terminated
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • Innsbruck, Austria
  • +9 more
Jun 25, 2019

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

Terminated
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Larkspur, California
  • +2 more
Nov 14, 2022

Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle

Recruiting
  • Metastatic Leiomyosarcoma
  • +17 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 13, 2022

Gastroesophageal Junction Adenocarcinoma, Malignant Tumor of the Cervical Esophagus, Malignant Tumor of the Thoracic Esophagus

Completed
  • Gastroesophageal Junction Adenocarcinoma
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 22, 2019

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in United States (drug,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Hsp90 inhibitor STA-9090
  • +7 more
  • Baltimore, Maryland
  • +3 more
Aug 19, 2018

Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)

Not yet recruiting
  • Sarcoma, Ewing
  • Rhabdomyosarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Solid Tumors, Non-small Cell Lung Carcinoma Trial in United States (DS-2248)

Terminated
Has Results
  • Solid Tumors
  • Non-small Cell Lung Carcinoma
  • Duarte, California
  • +8 more
Sep 9, 2021

Advanced Cancer Trial in United States (Mocetinostat - 50 mg, Mocetinostat - 70 mg, Mocetinostat - 90 mg)

Terminated
Has Results
  • Advanced Cancer
  • Mocetinostat - 50 mg
  • +4 more
  • Mobile, Alabama
  • +14 more
Mar 10, 2021

ER-Positive HER2-Negative Breast Cancer Trial in Worldwide (AZD9833, AZD9833 Placebo, Anastrozole)

Recruiting
  • ER-Positive HER2-Negative Breast Cancer
  • Phoenix, Arizona
  • +215 more
Aug 4, 2022